Irritable bowel syndrome genophenomics: correlation of serotonin-transporter polymorphisms and alosetron response.
Scherl
E
E
Division of Gastroenterology and Hepatology, The Weill Medical College of Cornell University, The New York Presbyterian Hospital, 520 E 70th Street, New York, NY 10021, USA.
Frissora
C L
CL
D002243:Carbolines / Q000627:therapeutic use*; D002352:Carrier Proteins / Q000235:genetics*; D017615:Enteric Nervous System / Q000503:physiopathology; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy* / Q000235:genetics*; D008562:Membrane Glycoproteins / Q000235:genetics*; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D050486:Serotonin Plasma Membrane Transport Proteins
D002243:Carbolines; D002352:Carrier Proteins; D005765:Gastrointestinal Agents; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; C493230:SLC6A4 protein, human; D012702:Serotonin Antagonists; D050486:Serotonin Plasma Membrane Transport Proteins; C090840:alosetron